Clinical Trials in Atlanta

Showing 15641-15660 of 19,805 trials

Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department

NCT02367274

A prospective, non-randomized trial for the extension and replication of the development database of brain electrical activity recordings and clinical information collected from patients who present to the ED following closed head injury.

Brain Injuries

BrainScope Company, Inc.421 participantsStarted Jan 2015

Hartford, Connecticut, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +8 more locations

COMPLETEDPhase 4< 1 mile

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

NCT00802867

Objectives: * To present the rates of adverse reactions after a dose of DAPTACEL® vaccine administered to children 4 to 6 years of age who have previously received four doses of PENTACEL™ vaccine. * To present immunogenicity before and after a single dose of DAPTACEL® vaccine administered to children 4 to 6 years of age who have previously received four doses of PENTACEL™ vaccine.

DiphtheriaTetanusPertussis+2 more

Sanofi Pasteur, a Sanofi Company989 participantsStarted Feb 2004

Jonesboro, Arkansas, United States • Little Rock, Arkansas, United States • Oakland, California, United States +16 more locations

Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Find Trials by Condition in Atlanta

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer

Fat Reduction in the Flanks Area vs. Control

Dose Comparison Study of Menactra® in US Children

Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)

Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

AMG 595 First-in-Human in Recurrent Gliomas

G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator